Yabo Hou,Xinxin Wang,Jianhua Chang et al.
Yabo Hou et al.
Eosinophilic cholangitis (EC) has a low clinical incidence, and cases with definitive pathological confirmation are extremely rare. Due to the lack of specificity in clinical and radiologic features, EC is frequently misdiagnosed as cholang...
Takahiro Yamada,Naoko Okano,Akihiko Matsumura et al.
Takahiro Yamada et al.
Background: The anatomical changes during carbon ion radiotherapy (CIRT) for head and neck cancers frequently require plan adaptations with adaptive re-planning. However, the details of the anatomical changes and their ra...
Duanyang Xu,Binghan Guo,Manxi Li et al.
Duanyang Xu et al.
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and represents the most frequent malignant lymphoma in adults. It typically occurs in sites such as the neck, axilla, and groin; however, lymphom...
Sara Torresan,Martina Bortolot,Elisa Bertoli et al.
Sara Torresan et al.
Background: Currently, there is no consensus on the optimal treatment sequence for NSCLC patients with class II-III BRAF mutations, where standard of care implies immunochemotherapy and scarce data on targeted therapy is ...
Neda Amirmokhtari,Forat Lutfi
Neda Amirmokhtari
There have been numerous advancements in immune cell effector therapies in the malignant hematology space. This review article explores the pivotal studies that led to the approval of chimeric antigen receptor T-cell (CAR-T) therapies for h...
Case Report: Coexistence of a giant borderline phyllodes tumor of the breast and a contralateral fibroadenoma: a challenging case with clinical manifestations and PET-CT imaging mimicking advanced cancer [0.03%]
Xin-Ru Wang,Qiang Zhang,Xing-Guo Cui
Xin-Ru Wang
Background: Phyllodes Tumor (PT) is a rare fibroepithelial tumor, which is classified into three categories: benign, borderline, and malignant. The three types show a gradually increasing trend in terms of local recurrenc...
Efficacy and safety of perioperative immune checkpoint inhibitors combined with chemotherapy versus chemotherapy alone for locally advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized phase III trials [0.03%]
Hai-Ting Zhang,Sun-Peng Xu,Wen-Jie Xie et al.
Hai-Ting Zhang et al.
Background: Phase III trials evaluating perioperative immune checkpoint inhibitors (ICIs) combined with chemotherapy for locally advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma have reported mixed effica...
Determinants of skeletal muscle loss during initial treatment in patients with ovarian cancer: a brief report [0.03%]
Naomi Nakayama,Daisaku Asai,Tomoka Ishibashi et al.
Naomi Nakayama et al.
Background: We previously reported that skeletal muscle loss during initial treatment is associated with poor outcomes in ovarian cancer. However, its clinical determinants remain incompletely understood. ...
Synergistic antitumor efficacy of a decorin-carrying oncolytic adenovirus combined with chemotherapy in pancreatic cancer [0.03%]
Jing Chen,Wei Ping Tian,Xiao Bai Wei et al.
Jing Chen et al.
Advances in gene engineering technology have led to the increasing clinical application of oncolytic adenovirus-targeted cancer therapy. Previous studies have demonstrated that oncolytic adenoviruses carrying decorin exhibit significant eff...
Development and validation of a multifactorial risk prediction model for breast cancer patients with co-occurring thyroid cancer: a retrospective matched case-control study [0.03%]
Junming Yin,Zhiwei Guo,Wen Yi et al.
Junming Yin et al.
Objective: To develop and validate a multifactorial machine learning model predicting thyroid cancer (TC) co-occurrence risk in breast cancer (BC) patients. ...